News & Events

Current News

Novartis and Microsoft join forces to develop drugs using AI

Alia Talaat

Novartis and Microsoft are joining forces to apply artificial intelligence to some of the most intractable problems in healthcare, in one of the most expansive tie-ups so far between big pharma and big tech.

Under one part of the five-year agreement, which will be reviewed annually, Microsoft will work on new tools intended to make it easier to apply AI to all areas of the Swiss pharmaceutical company’s business, from finance to manufacturing.

Read more.